243 related articles for article (PubMed ID: 30232699)
41. Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects.
Moon SJ; Jeon JY; Jang K; Yu KS; Lim Y; Kim MG
Drug Des Devel Ther; 2019; 13():2533-2542. PubMed ID: 31440035
[TBL] [Abstract][Full Text] [Related]
42. Amlodipine bioequivalence achieved with a very sensitive liquid chromatography tandem mass spectrometric bioassay.
Marzo A; Dal Bo L; Mazzucchelli P; Monti NC; Crivelli F; Ismaili S; Uhr MR; La Commare P
Arzneimittelforschung; 2000 Aug; 50(8):688-94. PubMed ID: 10994151
[TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
[TBL] [Abstract][Full Text] [Related]
44. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS
Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetic Drug Interactions Between Amlodipine, Valsartan, and Rosuvastatin in Healthy Volunteers.
Seong SJ; Ohk B; Kang WY; Gwon MR; Kim BK; Cho S; Yang DH; Lee HW; Yoon YR
Adv Ther; 2019 Jul; 36(7):1642-1656. PubMed ID: 31119689
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetic interactions of valsartan and hydrochlorothiazide: an open-label, randomized, 4-period crossover study in healthy Egyptian male volunteers.
Hedaya MA; Helmy SA
Clin Ther; 2013 Jun; 35(6):846-61. PubMed ID: 23795576
[TBL] [Abstract][Full Text] [Related]
47. Bioequivalence study of two formulations of bisoprolol fumarate film-coated tablets in healthy subjects.
Tjandrawinata RR; Setiawati E; Yunaidi DA; Santoso ID; Setiawati A; Susanto LW
Drug Des Devel Ther; 2012; 6():311-6. PubMed ID: 23139624
[TBL] [Abstract][Full Text] [Related]
48. Fixed-dose combination tablet of repaglinide and metformin is bioequivalent to concomitantly administered individual tablets of repaglinide and metformin : randomized, single-blind, three-period crossover study in healthy subjects.
Hoelscher D; Chu PL; Lyness W
Clin Drug Investig; 2008; 28(9):573-82. PubMed ID: 18666804
[TBL] [Abstract][Full Text] [Related]
49. Investigation of a potential pharmacokinetic interaction between perindopril arginine and amlodipine when administered as a single perindopril/amlodipine fixed-dose combination tablet in healthy Chinese male volunteers.
Zheng X; Liu T; Chen X; Chen X; Jiang J; Hu P
Int J Clin Pharmacol Ther; 2016 Jan; 54(1):43-51. PubMed ID: 26365335
[TBL] [Abstract][Full Text] [Related]
50. Bioequivalence study of an extemporaneously prepared oral solution of amlodipine suitable for use in pediatric patients compared to commercial tablets.
van der Vossen AC; van der Velde I; van den Meiracker AH; van der Nagel BC; Koch BC; Vulto AG; Hanff LM
Int J Clin Pharmacol Ther; 2016 Jan; 54(1):65-72. PubMed ID: 26558434
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics, Bioequivalence, and Safety Studies of Amlodipine Besylate in Healthy Subjects.
Chen B; Chen Z; Lv D; Sun Y; Chen H
Clin Pharmacol Drug Dev; 2022 Jun; 11(6):717-723. PubMed ID: 34981666
[TBL] [Abstract][Full Text] [Related]
52. Bioequivalence and Pharmacokinetic Study of 2 Edoxaban Tablets in Healthy Chinese Subjects.
Liu L; Li X; Liu Y; Xu B; Li Y; Yuan F; Zhang P; Tu S; Hu W
Clin Pharmacol Drug Dev; 2022 Dec; 11(12):1440-1446. PubMed ID: 35950601
[TBL] [Abstract][Full Text] [Related]
53. Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes.
Lingvay I; Beetz N; Sennewald R; Schuler-Metz A; Bertulis J; Loley C; Lang B; Lippert C; Lee J; Manning LS; Terada D
Postgrad Med; 2020 May; 132(4):337-345. PubMed ID: 32366156
[TBL] [Abstract][Full Text] [Related]
54. Bioequivalence study of two formulations of candesartan cilexetil tablet in healthy subjects under fasting conditions.
Tjandrawinata RR; Setiawati E; Yunaidi DA; Simanjuntak R; Santoso ID; Susanto LW
Drug Des Devel Ther; 2013; 7():841-7. PubMed ID: 23990709
[TBL] [Abstract][Full Text] [Related]
55. Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability.
Dennison TJ; Smith JC; Badhan RK; Mohammed AR
Drug Des Devel Ther; 2017; 11():811-826. PubMed ID: 28352156
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetics of rosuvastatin/olmesartan fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects.
Son H; Roh H; Lee D; Chang H; Kim J; Yun C; Park K
Clin Ther; 2013 Jul; 35(7):915-22. PubMed ID: 23810276
[TBL] [Abstract][Full Text] [Related]
57. Fed and Fasted Single-dose Assessment of Bioequivalence of Dapagliflozin and Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.
Boulton DW; Chang M; Griffen SC; Kitaura C; Lubin S; Pollack A; LaCreta F
Clin Ther; 2016 Jan; 38(1):99-109. PubMed ID: 26682500
[TBL] [Abstract][Full Text] [Related]
58. Bioequivalence and food effect of a fixed-dose combination of macitentan and tadalafil: Adaptive design in the COVID-19 pandemic.
Csonka D; Fishman V; Natarajan J; Stieltjes H; Armas D; Dishy V; Perez Ruixo JJ
Pharmacol Res Perspect; 2021 Oct; 9(5):e00846. PubMed ID: 34624174
[TBL] [Abstract][Full Text] [Related]
59. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
[TBL] [Abstract][Full Text] [Related]
60. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study.
Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q
Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]